• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BIO-RAD LABORATORIES, INC. LIQUICHEK CARDIAC MARKERS PLUS CONTROL LT, LEVEL 2; MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BIO-RAD LABORATORIES, INC. LIQUICHEK CARDIAC MARKERS PLUS CONTROL LT, LEVEL 2; MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED) Back to Search Results
Model Number 147
Device Problem Burst Container or Vessel (1074)
Patient Problem Laceration(s) (1946)
Event Date 05/10/2023
Event Type  malfunction  
Event Description
On (b)(6) 2023, an employee of siemens healthineers reported an accidental blood exposure and finger cut at laboratoire synlab sylab figeac at combe de lavayssière, 46100 figeac, france.The employee noted that while opening liquichek cardiac marker plus control lt, level 2, lot 67672 as part of a new automaton installation, the product bottle burst and caused cuts to the left index finger.A 5-day of antibiotics dose was given and tests for hiv, hcv, aghbs, and syphilis were conducted.Bio-rad technical service provided the product safety data sheet, as well as the instructions for use (ifu) and certificate of analysis for lot 67672.
 
Manufacturer Narrative
The instruction for use provided by bio-rad for testing the liquichek cardiac markers plus control lt indicated the product contains human source materials and should be considered potentially infectious and handled with the same precautions used with patient specimens in accordance with good laboratory practice.Each human donor unit used to manufacture this product was tested as required by fda accepted methods.Tests results were non-reactive for hepatitis b surface antigen (hbsag), antibody to hepatitis c (hcv), and antibody to hiv-1/hiv-2.This product may also contain other human source materials for which there are no approved tests.In accordance with good laboratory practice, all human source material should be considered potentially infectious and handled with the same precautions used with patient specimens.The company address information of the initial reporter was not provided to bio-rad.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
LIQUICHEK CARDIAC MARKERS PLUS CONTROL LT, LEVEL 2
Type of Device
MUITI-ANALYTE CONTROLS, ALL KINDS (ASSAYED)
Manufacturer (Section D)
BIO-RAD LABORATORIES, INC.
9500 jeronimo rd
irvine CA 92618 2017
Manufacturer (Section G)
BIO-RAD LABORATORIES, INC.
9500 jeronimo road
irvine 92618 2017
Manufacturer Contact
maria zeballos
9500 jeronimo road
irvine, CA 92618-2017
9499981200
MDR Report Key16947420
MDR Text Key315698428
Report Number2016706-2023-00002
Device Sequence Number1
Product Code JJY
UDI-Device Identifier00847661000730
UDI-Public00847661000730
Combination Product (y/n)N
Reporter Country CodeFR
PMA/PMN Number
K050537
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 05/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/17/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number147
Device Catalogue Number147
Device Lot Number67672
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received05/10/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/31/2021
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
Patient SexFemale
-
-